Gufic Biosciences Limited

Gufic Biosciences receives three USFDA Form 483 observations at Pithampur facility
Business Upturn · 23 Oct 2026
Gufic Biosciences USFDA Inspection Indore Plant 2026
Kalkine India · 23 Oct 2026
Gufic Biosciences Receives Three USFDA Observations for Indore Facility Inspection
Whalesbook · 23 Oct 2026
Gufic Biosciences (NSE:GUFICBIO): What Is the Special Window for Physical Share Transfer?
Kalkine India · 17 Oct 2026
Bodal Chemicals vs Gufic Biosciences vs Hexagon Nutrition: Which Stock Should You Track
Univest · 01 Oct 2026
Gufic Biosciences: Best Stock in Its Sector? Key Metrics
Univest · 25 Sep 2026
Gufic Biosciences NSE Penalty Waiver Rejected September 2026
Kalkine India · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.